Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

60.47 +1.29 (+2.18%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
21 22 Next >
My Take: 4 Strong Growth Stocks to Buy This Week
Be thankful for Wall Street's discounts on these potential market-beating stock ideas. 
Via The Motley Fool
It Is Time To Buy Hims & Hers Stock
Hims & Hers is a pharmaceutical marketing, product, and distribution firm with a telehealth component. 
Via Talk Markets
2 No-Brainer Stocks to Buy Right Now for Less Than $50
These rapidly expanding companies could make you richer, even with a minimal investment. 
Via The Motley Fool
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy. 
Via InvestorPlace
Top 5 Health Care Stocks That May Collapse In November
As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Is Hims & Hers Stock a Buy Now?
Investors may be overlooking an incredible growth opportunity with Hims & Hers stock. 
Via The Motley Fool
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
Hims and Hers Stock Analysis: Buy or Sell?
The healthcare company is demonstrating excellent revenue growth. 
Via The Motley Fool
Is This Underrated SPAC Deal Stock a No-Brainer Buy?
Hims & Hers Health is quietly building a strong telemedicine business. 
Via The Motley Fool
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Is Hims & Hers Health Stock a Buy After Strong Earnings?
The company reported another good quarter and announced a buyback. Is HIMS stock a buy? 
Via The Motley Fool
MSP Recovery, Uber, Hims & Hers Health, Celsius, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Hims & Hers Health Q3 Results Mixed But FY23 Revenue Guidance Raised, $50 Million Share Buyback
Hims & Hers Health, Inc. (NYSE: HIMS) shares are trading higher in Monday's after-hours session after the company reported third-quarter earnings. 
Via Benzinga
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
From Hims & Hers Health, Inc.
Via Business Wire
5 Companies Worth Watching Closely This Earnings Week
A couple of pandemic darlings are reporting earnings this week. Here's what I'm expecting. 
Via The Motley Fool
Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services
From Hims & Hers Health, Inc.
Via Business Wire
Where Will Hims & Hers Health Be in 5 Years?
The stock is cheap, but is Hims & Hers a good investment to add to your portfolio? 
Via The Motley Fool
Hims & Hers Names Khobi Brooklyn As Chief Communications Officer
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023
From Hims & Hers Health, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Growth Stocks That Can Rocket 98% to 108% Higher, According to Wall Street
The analysts who follow these stocks have some big expectations for the year ahead. 
Via The Motley Fool
Is Hims & Hers Health Stock a Buy Now?
Share prices are down 50% since touching $12 a share in May of this year. 
Via The Motley Fool
4 Top Stocks to Buy in October
Investors can expect volatility during earnings season, especially with growth stocks. 
Via The Motley Fool
Rocket Stocks: 3 Investments Primed to Skyrocket by Year’s End
Are you looking to invest in stocks that can skyrocket? Here are three stocks to buy now primed to skyrocket by year's end. 
Via InvestorPlace
2 Beaten-Down Growth Stocks That Could Rocket 107% to 127% Higher, According to Wall Street
These stocks have taken a tumble, but the investment bank analysts who follow them still think they can produce eye-popping returns. 
Via The Motley Fool
2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. (NASDAQ: ULTA) and Estee Lauder Co. (NYSE: EL) shares 
Via MarketBeat
3 Beaten-Down Growth Stocks to Buy Under $10
The markets are always looking forward, and you should, too. Here are three growth stocks to buy now. 
Via The Motley Fool
Hims & Hers Named on Fortune Media and Great Place to Work’s 2023 Best Workplaces in Health Care List
From Hims & Hers Health, Inc.
Via Business Wire
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.